+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Metabolomics Market by Component (Bioinformatics Tools & Services, Metabolomic Instruments), Indication (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674898
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The metabolomics market is undergoing rapid transformation, driven by ongoing innovation in analytical technologies, bioinformatics, and collaborative research initiatives. As organizations prioritize precision and systems-level insights, metabolomics has become pivotal in shaping advancements across pharmaceuticals, personalized medicine, and environmental monitoring.

Market Snapshot: Metabolomics Market Growth and Trends

The Metabolomics Market grew from USD 3.05 billion in 2024 to USD 3.39 billion in 2025. It is expected to continue growing at a CAGR of 11.38%, reaching USD 5.83 billion by 2030. This rapid pace of expansion signals high demand for metabolomic platforms as businesses span applications from cellular pathway studies to clinical diagnostics. Both established corporations and emerging players are investing in novel bioinformatics and instrumentation to enhance research outcomes.

Scope & Segmentation

  • Component Segmentation: Bioinformatics tools and services, such as database solutions and bespoke analytics platforms, as well as a wide range of detection and separation instruments covering mass spectrometry, nuclear magnetic resonance spectroscopy, high- and ultra-performance liquid chromatography, capillary electrophoresis, and surface-based mass analysis.
  • Indication Areas: Cardiovascular, metabolic, neurological, and oncological disorders, reflecting the integration of metabolomics in the management and understanding of diverse clinical pathologies.
  • Application Domains: Biomarker discovery for cancer and neurological disorders, drug discovery through metabolic pathway elucidation and target identification, environmental science initiatives encompassing residue and quality assessments, nutrigenomics with emphasis on cardiovascular and obesity research, personalized medicine protocols, and precision-driven toxicology testing.
  • End-User Segments: Academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies, each accelerating advances from discovery through commercial deployment.
  • Geographical Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (featuring United Kingdom, Germany, France, Saudi Arabia, South Africa, and others), and Asia-Pacific (including China, Japan, India, Australia, South Korea, and additional regional hubs).
  • Technology Focus: Integration of artificial intelligence, machine learning, Internet of Things, cloud-based analysis platforms, spatial metabolomics, and single-cell analytical approaches.

Key Takeaways

  • Convergence of metabolomics with other omics technologies drives a systems-level approach to biological research and diagnostics.
  • Collaborative frameworks are robust, spanning interdisciplinary research consortia and public-private partnerships focused on data sharing and protocol standardization.
  • Advancements in automation—especially high-throughput screening and cloud-based visualization—are streamlining laboratory workflows, accelerating multi-site research, and supporting rapid decision-making.
  • Regional funding priorities influence the adoption and harmonization of metabolomics technologies, with varying emphasis on clinical research, environmental monitoring, and population health management.
  • Emerging trends such as spatial metabolomics and single-cell analysis expand possibilities for detailed molecular characterization, supporting new frontiers in precision and translational medicine.

Tariff Impact: United States Trade Policy Reshaping Supply Chains

Recent United States tariffs have prompted organizations within the metabolomics sector to reassess procurement, cost structures, and supply chain strategies. Laboratories are exploring alternative sourcing models and regional manufacturing to maintain operational resilience. These shifts foster greater flexibility, drive localized supplier investments, and encourage maintenance agreements designed to counterbalance incremental trade-related costs.

Methodology & Data Sources

This report utilizes a comprehensive mix of primary interviews with laboratory directors, manufacturers, and regulatory experts, alongside secondary research from peer-reviewed publications, industry symposiums, and patent analyses. Data triangulation ensures insights remain comprehensive, up-to-date, and reliable.

Why This Report Matters

  • Empowers decision-makers with a multi-faceted view of technology, supply chain, and regulatory dynamics shaping the metabolomics domain.
  • Informs strategic planning with actionable insights tailored to component innovation, application trends, and regional market opportunities—supporting confident resource allocation.
  • Highlights the impact of collaborative frameworks and regulatory changes, helping senior leaders anticipate risk and capture growth.

Conclusion

Metabolomics is rapidly evolving, anchored by technology innovation and collaborative research models. Senior decision-makers equipped with nuanced, actionable insights can confidently guide organizational strategy and capitalize on emerging opportunities in this transformative market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and deep learning in high throughput untargeted metabolomics workflows for predictive biomarker identification
5.2. Advances in single cell and spatial metabolomics mapping metabolic heterogeneity within complex tissues for precision medicine applications
5.3. Development of multiplexed trapped ion mobility spectrometry mass spectrometry platforms for enhanced metabolome coverage and structural elucidation
5.4. Expansion of metabolomics driven personalized nutrition platforms leveraging gut microbiome metabolic profiling for tailored dietary interventions
5.5. Implementation of multi omics data integration frameworks combining metabolomics genomics proteomics and transcriptomics for holistic systems biology analysis
5.6. Emergence of portable and real time ambient ionization mass spectrometry devices for in situ environmental and clinical metabolic monitoring
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Metabolomics Market, by Component
8.1. Introduction
8.2. Bioinformatics Tools & Services
8.2.1. Bioinformatics Services
8.2.2. Bioinformatics Tools & Databases
8.3. Metabolomic Instruments
8.3.1. Detection Tools
8.3.1.1. Mass Spectrometry
8.3.1.2. Nuclear Magnetic Resonance Spectroscopy
8.3.1.3. Surface-based Mass Analysis
8.3.2. Separation Tools
8.3.2.1. Capillary Electrophoresis
8.3.2.2. Gas Chromatography
8.3.2.3. High-Performance Liquid Chromatography
8.3.2.4. Ultra Performance Liquid Chromatography
9. Metabolomics Market, by Indication
9.1. Introduction
9.2. Cardiovascular Disorders
9.3. Metabolic Disorders
9.4. Neurological Disorders
9.5. Oncological Disorders
10. Metabolomics Market, by Application
10.1. Introduction
10.2. Biomarker Discovery
10.2.1. Cancer Biomarkers
10.2.2. Neurological Biomarkers
10.3. Drug Discovery
10.3.1. Metabolic Pathways
10.3.2. Target Identification
10.4. Environmental Science
10.4.1. Pesticide Residue Analysis
10.4.2. Water Quality Analysis
10.5. Nutrigenomics
10.5.1. Cardiovascular Health
10.5.2. Obesity Research
10.6. Personalized Medicine
10.6.1. Genomic Studies
10.6.2. Therapeutic Monitoring
10.7. Toxicology Testing
11. Metabolomics Market, by End-User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Pharmaceutical & Biotechnology Companies
12. Americas Metabolomics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Metabolomics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Metabolomics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Afekta Technologies Ltd.
15.3.2. BASF SE
15.3.3. Bio-Rad Laboratories, Inc.
15.3.4. Biocrates Life Science AG
15.3.5. Bruker Corporation
15.3.6. Clinical Microbiomics A/S
15.3.7. Danaher Corporation
15.3.8. DNA Xperts Private Limited
15.3.9. General Metabolics
15.3.10. Hitachi High-Tech Corporation
15.3.11. Human Metabolome Technologies Inc.
15.3.12. JASCO Corporation
15.3.13. Kore Technology Limited
15.3.14. LECO Corporation
15.3.15. Merck KGaA
15.3.16. Metabolon, Inc.
15.3.17. Shimadzu Corporation
15.3.18. Techcomp Europe Ltd
15.3.19. Thermo Fisher Scientific Inc.
15.3.20. Waters Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. METABOLOMICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. METABOLOMICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. METABOLOMICS MARKET: RESEARCHAI
FIGURE 24. METABOLOMICS MARKET: RESEARCHSTATISTICS
FIGURE 25. METABOLOMICS MARKET: RESEARCHCONTACTS
FIGURE 26. METABOLOMICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. METABOLOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL METABOLOMICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL METABOLOMICS MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL METABOLOMICS MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC PATHWAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC PATHWAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL METABOLOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL METABOLOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL METABOLOMICS MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL METABOLOMICS MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL METABOLOMICS MARKET SIZE, BY WATER QUALITY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL METABOLOMICS MARKET SIZE, BY WATER QUALITY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL METABOLOMICS MARKET SIZE, BY OBESITY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL METABOLOMICS MARKET SIZE, BY OBESITY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL METABOLOMICS MARKET SIZE, BY GENOMIC STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL METABOLOMICS MARKET SIZE, BY GENOMIC STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL METABOLOMICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL METABOLOMICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 164. CANADA METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 165. CANADA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 166. CANADA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 167. CANADA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. CANADA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. CANADA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 170. CANADA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 171. CANADA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 172. CANADA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 173. CANADA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. CANADA METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. CANADA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. CANADA METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. CANADA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 178. CANADA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 179. CANADA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 180. CANADA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 181. CANADA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 182. CANADA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 183. CANADA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 184. CANADA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 185. CANADA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 186. CANADA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 187. CANADA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 188. CANADA METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 190. MEXICO METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 191. MEXICO METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 192. MEXICO METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 193. MEXICO METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. MEXICO METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. MEXICO METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 204. MEXICO METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 205. MEXICO METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 206. MEXICO METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 207. MEXICO METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. MEXICO METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM METABOLOMICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 321. GERMANY METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 322. GERMANY METABOLOMICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 323. GERMANY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2024 (USD MILLION)
TABLE 324. GERMANY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2025-2030 (USD MILLION)
TABLE 325. GERMANY METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 326. GERMANY METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 327. GERMANY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2024 (USD MILLION)
TABLE 328. GERMANY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2025-2030 (USD MILLION)
TABLE 329. GERMANY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2024 (USD MILLION)
TABLE 330. GERMANY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2025-2030 (USD MILLION)
TABLE 331. GERMANY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 332. GERMANY METABOLOMICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 333. GERMANY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. GERMANY METABOLOMICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. GERMANY METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 336. GERMANY METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 337. GERMANY METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 338. GERMANY METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 339. GERMANY METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2024 (USD MILLION)
TABLE 340. GERMANY METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2025-2030 (USD MILLION)
TABLE 341. GERMANY METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2024 (USD MILLION)
TABLE 342. GERMANY METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2025-2030 (USD MILLION)
TABLE 343. GERMANY METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD M

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Metabolomics market report include:
  • Afekta Technologies Ltd.
  • BASF SE
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Science AG
  • Bruker Corporation
  • Clinical Microbiomics A/S
  • Danaher Corporation
  • DNA Xperts Private Limited
  • General Metabolics
  • Hitachi High-Tech Corporation
  • Human Metabolome Technologies Inc.
  • JASCO Corporation
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • Metabolon, Inc.
  • Shimadzu Corporation
  • Techcomp Europe Ltd
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Table Information